![Barbara Domayne Hayman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Barbara Domayne Hayman
Mitglied des Investmentausschusses bei
Cambridge Enterprise Ltd.
Profil
Barbara Domayne Hayman is currently an Investment Committee member at Cambridge Enterprise Ltd. and the Chief Business Officer at Autifony Therapeutics Ltd. She holds a doctorate degree from the University of Oxford.
Aktive Positionen von Barbara Domayne Hayman
| Unternehmen | Position | Beginn |
|---|---|---|
Cambridge Enterprise Ltd.
 Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Mitglied des Investmentausschusses | - |
Autifony Therapeutics Ltd.
 Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Corporate Officer/Principal | - |
Ausbildung von Barbara Domayne Hayman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
18
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Enterprise Ltd.
Cambridge Enterprise Ltd. Investment ManagersFinance CEL invests in companies located in the United Kingdom. The firm targets companies operating in the fields of pharmaceuticals, electronics, software and engineering. It provide financing for early stage capital requirements. | Finance |
Autifony Therapeutics Ltd.
Autifony Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops new pharmaceutical treatments treat hearing disorders | Health Technology |
